Jason Chin
Direktor/Vorstandsmitglied bei GENUS PLC
Aktive Positionen von Jason Chin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENUS PLC | Direktor/Vorstandsmitglied | 01.04.2021 | - |
| Independent Dir/Board Member | 01.04.2021 | - | |
Constructive Bio Ltd.
 Constructive Bio Ltd. BiotechnologyHealth Technology Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself. | Direktor/Vorstandsmitglied | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Gründer | - | - |
Karriereverlauf von Jason Chin
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Process Industries | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENUS PLC | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Constructive Bio Ltd.
Constructive Bio Ltd. BiotechnologyHealth Technology Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself. | Health Technology |
- Börse
- Insiders
- Jason Chin
- Erfahrung
